BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7344123)

  • 1. Immunogenetic studies of Sjögren's syndrome.
    Nakao Y; Fujita T; Yamauchi Y; Ishikawa H; Hirohata K; Miyawaki S; Suginoshita T; Matsumoto H; Tsuji K
    Ryumachi; 1981; 21 Suppl():135-40. PubMed ID: 7344123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Humoral reactivity against the secretory component of secretory IgA in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus].
    Luft S; Brzezińska B; Wójcik-Scisłowska M; Małdykowa H; Pazdur J; Strauss MM
    Reumatologia; 1979; 17(2):137-43. PubMed ID: 472524
    [No Abstract]   [Full Text] [Related]  

  • 3. Reticuloendothelial Fc receptor function in patients with Sjogren's syndrome.
    O'Sullivan MM; Walker DM; Williams BD
    Clin Exp Immunol; 1985 Sep; 61(3):483-8. PubMed ID: 4075586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of anti-Fc gamma receptor autoantibodies is related to the clinical presentation of primary Sjögren's syndrome.
    Lamour A; Le Corre R; Pennec YL; Youinou P
    J Rheumatol; 1995 Dec; 22(12):2241-5. PubMed ID: 8835556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid gland disorders in primary Sjögren's syndrome.
    Punzi L; Ostuni PA; Betterle C; De Sandre P; Botsios C; Gambari PF
    Rev Rhum Engl Ed; 1996 Dec; 63(11):809-14. PubMed ID: 9010968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies of primary Sjögren's syndrome].
    Taneichi K; Shibaki H
    Nihon Naika Gakkai Zasshi; 1988 Oct; 77(10):1540-5. PubMed ID: 3266638
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of the nervous system and HLA phenotype in primary Sjogren's syndrome.
    Panchovska MS; Sheitanov YI; Martinova FG
    Minerva Med; 2003 Feb; 94(1):57-8. PubMed ID: 12719703
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
    Mattey DL; González-Gay MA; Hajeer AH; Dababneh A; Thomson W; García-Porrúa C; Ollier WE
    J Rheumatol; 2000 Nov; 27(11):2611-6. PubMed ID: 11093441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study.
    Tunc R; Gonen MS; Acbay O; Hamuryudan V; Yazici H
    Ann Rheum Dis; 2004 May; 63(5):575-7. PubMed ID: 15082490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The HLA-DR determinants in chronic inflammatory rheumatism].
    Chalès G; Fauchet R; Pawlotsky Y; Gueguen M; Coutard J; Duval A; Pittie P
    Rev Rhum Mal Osteoartic; 1983 Jun; 50(7):525-31. PubMed ID: 6193576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fc gamma receptors of polymorphonuclear neutrophils. A study of the clinical and biological correlations in patients with rheumatoid polyarthritis].
    Le Goff P; Lepoivre B; Jouquan J; Muzellec Y; Boudon A; Youinou P
    Rev Rhum Mal Osteoartic; 1988 May; 55(7):545-9. PubMed ID: 3175513
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical relevance of antiphospholipid antibodies in rheumatology].
    Gromnica-Ihle E; Franz J
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):525-9. PubMed ID: 7856256
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-cyclic citrullinated peptide antibodies in patients with primary Sjögren's syndrome.
    Tobón GJ; Correa PA; Anaya JM
    Ann Rheum Dis; 2005 May; 64(5):791-2. PubMed ID: 15834066
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidermal IgG deposits in patients with primary Sjögren's syndrome].
    Oxholm A; Manthorpe R; Oxholm P
    Ugeskr Laeger; 1985 Jan; 147(4):261-4. PubMed ID: 3883608
    [No Abstract]   [Full Text] [Related]  

  • 16. [Expanded clinical and basic profile of rheumatoid factors. 6. Rheumatoid factors in patients with Sjögren's syndrome].
    Ezaki I; Wada T; Nonaka S; Kamimiya M; Nobenaga T
    Ryumachi; 1988 Dec; 28(6):425-8. PubMed ID: 3249981
    [No Abstract]   [Full Text] [Related]  

  • 17. Nervous system disease, immunological features, and HLA phenotype in Sjögren's syndrome.
    Hietaharju A; Korpela M; Ilonen J; Frey H
    Ann Rheum Dis; 1992 Apr; 51(4):506-9. PubMed ID: 1586250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
    Szántó A; Csípo I; Zeher M
    J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-Bw44 and HLA-DRw4 in male Sjögren's syndrome patients with associated rheumatoid arthritis.
    Powell TR; Michalski JP; McCombs CC; Danilovs JA; Terasaki PI; Park MS; Flood T; Boone WB
    Clin Immunol Immunopathol; 1980 Nov; 17(3):463-8. PubMed ID: 6933029
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis and identification of rheumatoid factors in tears in Gougerot-Sjögren syndrome].
    Damillière B; Roudier R; Boidin C; Partouche P
    Bull Soc Ophtalmol Fr; 1985 Dec; 85(12):1365-72. PubMed ID: 2436823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.